Polypid Ltd. (PYPD) SEC Filings — 2025
19 SEC filings for Polypid Ltd. (PYPD) in 2025.
Filings
- PolyPid Ltd. Calls Extraordinary General Meeting for Feb 4, 2026 — 6-K · Dec 31, 2025
- PolyPid Appoints Brooke Story as New Chairman — 6-K · Dec 16, 2025
- Polypid Ltd. 6-K Filing — 6-K · Dec 3, 2025
- PolyPid Ltd. Boosts Share Offering Size to $15M — 6-K · Nov 26, 2025
- Polypid Ltd. 6-K Filing — 6-K · Nov 12, 2025
- PolyPid Clears Israeli Health Ministry GMP Inspection — 6-K · Sep 16, 2025
- PolyPid Ltd. Appoints Nir Dror as Interim Chairman — 6-K · Aug 13, 2025
- PolyPid Appoints Dr. Nurit Tweezer-Zaks as Chief Medical Officer — 6-K · Aug 12, 2025
- PolyPid Launches GLP-1 Delivery Platform for Diabetes/Weight Loss — 6-K · Jul 15, 2025
- PolyPid Ltd. Holds Shareholder Meeting, Re-elects Auditors — 6-K · Jun 25, 2025
- PolyPid Ltd. Inducement Offer for January 2024 Warrants — 6-K · Jun 17, 2025
- PolyPid's D-PLEX 100 Hits Endpoints in Phase 3 SHIELD II Trial — 6-K · Jun 9, 2025
- PolyPid Ltd. Boosts Share Option Plan by 1.2M Shares — 6-K · May 30, 2025
- PolyPid Ltd. Announces Shareholder Meeting for June 25 — 6-K · May 21, 2025
- PolyPid Ltd. Reports Q1 2025 Financials and Corporate Update — 6-K · May 14, 2025
- PolyPid Completes Enrollment in Phase 3 D-PLEX 100 Surgical Infection Trial — 6-K · Mar 11, 2025
- PolyPid Ltd. Files 2024 Annual Report — 20-F · Feb 26, 2025
- PolyPid Ltd. Appoints New Director — 6-K · Feb 12, 2025
- PolyPid Faces Nasdaq Delisting Over Equity Shortfall — 6-K · Jan 17, 2025